Elsevier

Experimental Eye Research

Volume 127, October 2014, Pages 91-103
Experimental Eye Research

Diabetes induces changes in KIF1A, KIF5B and dynein distribution in the rat retina: Implications for axonal transport

https://doi.org/10.1016/j.exer.2014.07.011Get rights and content

Highlights

  • Kinesin and dynein motor proteins are altered in the retinas of diabetic rats.

  • High glucose per se did not lead to changes in motor proteins in retinal neurons.

  • Other factors, like inflammation, may contribute for the alterations in motor proteins.

Abstract

Diabetic retinopathy is a leading cause of vision loss and blindness. Disruption of axonal transport is associated with many neurodegenerative diseases and might also play a role in diabetes-associated disorders affecting nervous system. We investigated the impact of type 1 diabetes (2 and 8 weeks duration) on KIF1A, KIF5B and dynein motor proteins in the retina. Additionally, since hyperglycemia is considered the main trigger of diabetic complications, we investigated whether prolonged exposure to elevated glucose could affect the content and distribution of motor proteins in retinal cultures. The immunoreactivity of motor proteins was evaluated by immunohistochemistry in retinal sections and by immunoblotting in total retinal extracts from streptozotocin-induced diabetic and age-matched control animals. Primary retinal cultures were exposed to high glucose (30 mM) or mannitol (osmotic control; 24.5 mM plus 5.5 mM glucose), for seven days. Diabetes decreased the content of KIF1A at 8 weeks of diabetes as well as KIF1A immunoreactivity in the majority of retinal layers, except for the photoreceptor and outer nuclear layer. Changes in KIF5B immunoreactivity were also detected by immunohistochemistry in the retina at 8 weeks of diabetes, being increased at the photoreceptor and outer nuclear layer, and decreased in the ganglion cell layer. Regarding dynein immunoreactivity there was an increase in the ganglion cell layer after 8 weeks of diabetes. No changes were detected in retinal cultures. These alterations suggest that axonal transport may be impaired under diabetes, which might contribute to early signs of neural dysfunction in the retina of diabetic patients and animal models.

Introduction

Diabetic retinopathy is the most common microvascular complication of diabetes mellitus and is a leading cause of vision loss and blindness among working-age adults in Western countries. However, increasing evidence has shown that the neural components of the retina are also affected (Antonetti et al., 2006). Alterations in electroretinograms in diabetic patients and animals, and loss of color and contrast sensitivity are early signs of neural dysfunction in the retina (Roy et al., 1986, Daley et al., 1987, Sakai et al., 1995), demonstrating that the neural retina can be also affected by this disease.

Neurons are highly polarized cells, with long axons, which constitute a major challenge to the movement of proteins, vesicles, and organelles between cell bodies and presynaptic sites. To overcome this, neurons possess specialized transport machinery consisting of cytoskeletal motor proteins (kinesins and dynein) generating directed movements along cytoskeletal tracks. Axonal transport motor proteins require ATP demands, which implies the localization of functional mitochondria along the axons. Mobile mitochondria can become stationary or pause in regions that have a high metabolic demand and can move again rapidly in response to physiological changes. Defects in mitochondrial transport are implicated in the pathogenesis of several major neurological disorders (Sheng and Cai, 2012). Axonal transport is therefore crucial to maintain neuronal viability, and any impairment in this transport may play a role in the development or progression of several diseases (De Vos et al., 2008).

A decrease in the levels of mRNAs encoding for neurofilament proteins was found in the dorsal root ganglia of streptozocin-induced diabetic rats (Mohiuddin et al., 1995). Additionally, slow axonal transport of neurofilament and microtubule components is reduced, leading to a decrease in axonal caliber (Medori et al., 1988). These evidences suggest that deficits in axonal transport may contribute to neuronal changes observed in diabetes in neural tissues. To our knowledge, only a few studies have evaluated the effect of diabetes on axonal transport in the retina and most of them have focused in studying fluoro-gold labeling in retinal ganglion cells (RGCs) (Zhang et al., 1998, Ino-Ue et al., 2000, Zhang et al., 2000). Despite these evidences, the impact of diabetes in motor proteins (kinesins and dynein) in the retina has not been addressed. Nevertheless, potential changes in their content and distribution might underlie some changes already observed in axonal transport in the retina and visual pathway under diabetic conditions (Zhang et al., 2000, Fernandez et al., 2012).

Previously, we found that diabetes changes the levels of several synaptic proteins in retinal nerve terminals, with no changes in total retinal extracts, suggesting that axonal transport of those proteins may be impaired in diabetes (Gaspar et al., 2010a). Hyperglycemia is considered the main pathogenic factor for the development of diabetic complications. We found that high glucose leads to an accumulation of vesicular glutamate transporter-1, syntaxin-1 and synaptotagmin-1 at the cell body in hippocampal cell cultures, further suggesting that axonal transport of these proteins to nerve terminals might be affected under hyperglycemic conditions (Gaspar et al., 2010b). Recently, we showed that mRNA levels and the content of kinesin motor proteins are altered in the hippocampus of diabetic rats (Baptista et al., 2013). We also demonstrated that high glucose leads to changes in the immunoreactivity of motor proteins and synaptic proteins specifically in the axons of hippocampal neurons further suggesting that anterograde axonal transport may be impaired in the hippocampus (Baptista et al., 2013). These changes detected in the hippocampus of diabetic rats lead us to check whether similar changes could also be occurring in the retina under diabetes. Therefore, in this work, we aimed to study the effect of diabetes and also high glucose per se (prolonged exposure for 7 days), mimicking hyperglycemic conditions, on the content and distribution of the motor proteins KIF1A (kinesin that transports synaptic vesicle precursors), KIF5B (kinesin involved in mitochondrial transport and in the transport of synaptic vesicle precursors and membrane organelles) and dynein (motor protein for retrograde axonal transport) in diabetic animals and primary rat retinal cell cultures. Since motor proteins need ATP to carry cargoes along the axons, the distribution of mitochondria was also analyzed in retinal neural cell cultures exposed to high glucose.

Section snippets

Animals

Male Wistar rats (Charles River Laboratories), eight weeks-old, were randomly assigned to control or diabetic groups. All procedures were in agreement with the EU Directive 2010/63/EU for animal experiments. Diabetes was induced with a single intraperitoneal injection of streptozotocin (STZ; 65 mg/kg, freshly dissolved in 10 mM sodium citrate buffer, pH 4.5) (Sigma, St. Louis, MO, USA). Hyperglycemic status (blood glucose levels exceeding 250 mg/dl) was confirmed two days after STZ injection

Animal body weight and glucose blood levels

Animal body weight assessed prior the induction of diabetes was similar between the two groups (255.7 ± 3.5 g for control animals and 253.4 ± 3.4 g for diabetic group), as well as the blood glucose levels (89.1 ± 1.4 mg/dl for controls and 86.7 ± 5.7 mg/dl for diabetic group). The average weight and blood glucose levels for both diabetic and aged-matched control rats at the time of death are given in Table 3. A marked impairment in weight gain occurred in diabetic rats comparing to age-matched

Discussion

In the current study, we evaluated the impact of diabetes and elevated glucose on key proteins involved in axonal transport in retinal cells. We show that diabetes alters the content of KIF1A and the distribution of KIF1A, KIF5B and dynein along retinal layers at 8 weeks of diabetes, suggesting that anterograde and retrograde transport mediated by these motor proteins may be impaired.

Previously, we have demonstrated that the mRNA levels and content of KIF1A and KIF5B motor proteins are altered

Conclusions

In summary, our data demonstrate that diabetes leads to changes in KIF1A, KIF5B and dynein motor proteins, which may contribute to impairments in anterograde and retrograde axonal transport and consequently to neuronal dysfunction in the retina. The changes observed may be due to insulin deficiency or inflammation rather than hyperglycemia, or to a synergistic combination of these factors.

Acknowledgments

This work was supported by PEst-C/SAU/UI3282/2011-2013 and PEst-C/SAU/LA0001/2013-2014 (FCT, Portugal, and COMPETE). Filipa I. Baptista and Maria J. Pinto acknowledge fellowships from Fundação para a Ciência e a Tecnologia, Portugal (SFRH/BD/35961/2007 and SFRH/BD/51196/2010, respectively). Ramiro D. Almeida is supported by FEDER through COMPETE and by FCT (PTDC/SAU-NEU/104100/2008) and by Marie Curie Actions, 7th Framework Programme, EU.

References (51)

  • J. Kuribayashi et al.

    Kinesin-1 and degenerative changes in optic nerve axons in NMDA-induced neurotoxicity

    Brain Res.

    (2010)
  • L.A. Ligon et al.

    A direct interaction between cytoplasmic dynein and kinesin I may coordinate motor activity

    J. Biol. Chem.

    (2004)
  • K.R. Martin et al.

    Optic nerve dynein motor protein distribution changes with intraocular pressure elevation in a rat model of glaucoma

    Exp. Eye Res.

    (2006)
  • C.E. Reiter et al.

    Functions of insulin and insulin receptor signaling in retina: possible implications for diabetic retinopathy

    Prog. Retin Eye Res.

    (2003)
  • A.R. Santiago et al.

    High glucose and diabetes increase the release of [3H]-D-aspartate in retinal cell cultures and in rat retinas

    Neurochem Int.

    (2006)
  • G.M. Seigel et al.

    Systemic IGF-I treatment inhibits cell death in diabetic rat retina

    J. Diabetes Complicat.

    (2006)
  • C. van Oterendorp et al.

    The expression of dynein light chain DYNLL1 (LC8-1) is persistently downregulated in glaucomatous rat retinal ganglion cells

    Exp. Eye Res.

    (2011)
  • D.A. Antonetti et al.

    Diabetic retinopathy: seeing beyond glucose-induced microvascular disease

    Diabetes

    (2006)
  • P. Avasthi et al.

    Trafficking of membrane proteins to cone but not rod outer segments is dependent on heterotrimeric kinesin-II

    J. Neurosci.

    (2009)
  • F.I. Baptista et al.

    Diabetes alters KIF1A and KIF5B motor proteins in the hippocampus

    PloS One

    (2013)
  • A.J. Barber et al.

    Altered expression of retinal occludin and glial fibrillary acidic protein in experimental diabetes. The Penn State Retina Research Group

    Invest Ophthalmol. Vis. Sci.

    (2000)
  • A.J. Barber et al.

    The Ins2Akita mouse as a model of early retinal complications in diabetes

    Invest Ophthalmol. Vis. Sci.

    (2005)
  • A.J. Barber et al.

    Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin

    J. Clin. Invest

    (1998)
  • S. Baumann et al.

    Kinesin-3 and dynein mediate microtubule-dependent co-transport of mRNPs and endosomes

    J. Cell. Sci.

    (2012)
  • A. Carmo et al.

    Effect of cyclosporin-A on the blood–retinal barrier permeability in streptozotocin-induced diabetes

    Mediat. Inflamm.

    (2000)
  • Cited by (26)

    • Targeted pharmacotherapy against neurodegeneration and neuroinflammation in early diabetic retinopathy

      2021, Neuropharmacology
      Citation Excerpt :

      It appears that this RGC impairment might be caused at least in part by a diabetes-induced decrease in the content of synaptic proteins in retinal nerve terminals (Gaspar et al., 2010; VanGuilder et al., 2008). It has also been shown in rats 6–8 weeks after STZ injection that diabetes may reduce both the retrograde and anterograde RGC axonal transport efficiency, which could further contribute to RGC impairment and loss of normal function (Fernandez et al., 2012; Baptista et al., 2014). Recently, we and others have observed that synaptic dysfunction of RGCs is an early sign of neurodegeneration prior to their apoptosis in DR (Zhu et al., 2018; VanGuilder et al., 2008).

    • Inflammatory cells proliferate in the choroid and retina without choroidal thickness change in early Type 1 diabetes

      2020, Experimental Eye Research
      Citation Excerpt :

      Male Wistar Han rats (8-weeks old) were randomly assigned to T1D (n = 16) and control (n = 12) experimental groups. T1D was induced with a single intra-peritoneal injection of STZ (65 mg/kg), freshly dissolved in 10 mM sodium citrate buffer, pH 4.5, (Sigma, St. Louis, MO, USA) (Baptista et al., 2014). Hyperglycaemic status (glycaemia>250 mg/dL) was confirmed two days later using a glucometer (Ascensia ELITE™, Bayer Corporation, Mishawaka, IN, USA).

    • Porous poly(ε-caprolactone) implants: A novel strategy for efficient intraocular drug delivery

      2019, Journal of Controlled Release
      Citation Excerpt :

      For each condition, 10 images per coverslip were randomly acquired with a 20× objective (Plan Achromat 20×/0.8 M27). Retinas were lysed in ice-cold radioimmunoprecipitation assay (RIPA) buffer (50 mM Tris, 150 mM NaCl, 5 mM EGTA, 1 % Triton X-100, 0.5 % DOC, 0.1 % SDS) supplemented with 1 mM dithiothreitol (DTT, Sigma-Aldrich, Missouri, USA), complete miniprotease inhibitor cocktail tablets (Roche, Sigma-Aldrich, Missouri, USA) and phosphatase inhibitors (10 mM NaF and 1 mM Na3VO4) and protein extracts were prepared as previously described [36]. Samples (20 μg of protein) were separated in 8 % sodium dodecyl sulphate-poly(acrylamide) gel electrophoresis (SDS-PAGE) and the proteins were transferred electrophoretically to poly(vinylidene difluoride) (PVDF) membranes.

    View all citing articles on Scopus
    View full text